These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients: the Institut Gustave Roussy experience. Farhat F; Culine S; Théodore C; Békradda M; Terrier-Lacombe MJ; Droz JP Cancer; 1996 Mar; 77(6):1193-7. PubMed ID: 8635143 [TBL] [Abstract][Full Text] [Related]
9. Nonseminomatous germ cell tumors of the testis: current concepts and controversies. Sheinfeld J Urology; 1994 Jul; 44(1):2-14. PubMed ID: 7518979 [No Abstract] [Full Text] [Related]
10. Long-term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy. Beyer J; Kingreen D; Krause M; Schleicher J; Schwaner I; Schwella N; Huhn D; Siegert W Cancer; 1997 Jan; 79(1):161-8. PubMed ID: 8988741 [TBL] [Abstract][Full Text] [Related]
11. Late relapse of nonseminomatous germ cell tumor of the testis: successful treatment with salvage chemotherapy alone. Papadimitris C; Papadimitriou C; Kokolakis N; Athanassiades P; Dimopoulos MA Urology; 1997 Mar; 49(3):469-70. PubMed ID: 9123720 [TBL] [Abstract][Full Text] [Related]
12. Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer. Motzer RJ; Sheinfeld J; Mazumdar M; Bains M; Mariani T; Bacik J; Bajorin D; Bosl GJ J Clin Oncol; 2000 Jun; 18(12):2413-8. PubMed ID: 10856101 [TBL] [Abstract][Full Text] [Related]
13. Chemotherapy in patients with metastatic or relapsed germ-cell tumours. Rick O; Siegert W; Beyer J Cancer Treat Rev; 2001 Oct; 27(5):283-8. PubMed ID: 11871864 [TBL] [Abstract][Full Text] [Related]
14. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group. Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C; J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987 [TBL] [Abstract][Full Text] [Related]
15. Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy. Kondagunta GV; Sheinfeld J; Mazumdar M; Mariani TV; Bajorin D; Bacik J; Bosl GJ; Motzer RJ J Clin Oncol; 2004 Feb; 22(3):464-7. PubMed ID: 14752068 [TBL] [Abstract][Full Text] [Related]
16. Current trends in chemotherapy for metastatic nonseminomatous testicular germ cell tumors. Bokemeyer C Oncology; 1998; 55(3):177-88. PubMed ID: 9560052 [TBL] [Abstract][Full Text] [Related]
17. High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults. Lotz JP; André T; Donsimoni R; Firmin C; Bouleuc C; Bonnak H; Merad Z; Esteso A; Gerota J; Izrael V Cancer; 1995 Feb; 75(3):874-85. PubMed ID: 7828139 [TBL] [Abstract][Full Text] [Related]
18. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours. Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204 [TBL] [Abstract][Full Text] [Related]
19. High-dose salvage chemotherapy. Germ-cell tumor treatment results in Germany. Rick O; Siegert W; Beyer J Int J Cancer; 1999 Dec; 83(6):839-40. PubMed ID: 10597206 [TBL] [Abstract][Full Text] [Related]
20. Salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in relapsed or cisplatin-refractory germ cell tumors. Park S; Lee S; Lee J; Park SH; Park JO; Kang WK; Park YS; Lim HY Onkologie; 2011; 34(8-9):416-20. PubMed ID: 21934340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]